Video Upload Options

References

1. "Purification and characterization of hypoxia-inducible factor 1". The Journal of Biological Chemistry 270 (3): 1230–7. January 1995. doi:10.1074/jbc.270.3.1230. PMID 7836384.  https://dx.doi.org/10.1074%2Fjbc.270.3.1230
2. "Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension". Proceedings of the National Academy of Sciences of the United States of America 92 (12): 5510–4. June 1995. doi:10.1073/pnas.92.12.5510. PMID 7539918. Bibcode: 1995PNAS...92.5510W.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=41725
3. "Hypoxia and hypoxia inducible factors (HIF) as important regulators of tumor physiology". Cancer Treatment and Research 117: 219–48. 2004. doi:10.1007/978-1-4419-8871-3_14. ISBN 978-1-4613-4699-9. PMID 15015563.  https://dx.doi.org/10.1007%2F978-1-4419-8871-3_14
4. "Oxygen sensing – an essential process for survival". Albert Lasker Basic Medical Research Award. Albert And Mary Lasker Foundation. 2016. http://www.laskerfoundation.org/awards/show/oxygen-sensing-essential-process-survival/. 
5. "How cells sense and adapt to oxygen availability". The Nobel Prize in Physiology or Medicine 2019. NobelPrize.org. Nobel Media AB. 7 October 2019. https://www.nobelprize.org/prizes/medicine/2019/press-release/. 
6. "Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension". Proceedings of the National Academy of Sciences of the United States of America 92 (12): 5510–4. June 1995. doi:10.1073/pnas.92.12.5510. PMID 7539918. Bibcode: 1995PNAS...92.5510W.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=41725
7. "Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1". The Journal of Biological Chemistry 271 (30): 17771–8. July 1996. doi:10.1074/jbc.271.30.17771. PMID 8663540.  https://dx.doi.org/10.1074%2Fjbc.271.30.17771
8. "PAS domain S-boxes in Archaea, Bacteria and sensors for oxygen and redox". Trends in Biochemical Sciences 22 (9): 331–3. September 1997. doi:10.1016/S0968-0004(97)01110-9. PMID 9301332.  https://dx.doi.org/10.1016%2FS0968-0004%2897%2901110-9
9. "PAS: a multifunctional domain family comes to light". Current Biology 7 (11): R674–7. November 1997. doi:10.1016/S0960-9822(06)00352-6. PMID 9382818.  https://dx.doi.org/10.1016%2FS0960-9822%2806%2900352-6
10. "Functions of the Per/ARNT/Sim domains of the hypoxia-inducible factor". The Journal of Biological Chemistry 280 (43): 36047–54. October 2005. doi:10.1074/jbc.M501755200. PMID 16129688.  https://dx.doi.org/10.1074%2Fjbc.M501755200
11. "Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling". Science 296 (5574): 1886–9. June 2002. doi:10.1126/science.1073440. PMID 12004076. Bibcode: 2002Sci...296.1886M.  https://dx.doi.org/10.1126%2Fscience.1073440
12. "Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha". Proceedings of the National Academy of Sciences of the United States of America 99 (8): 5367–72. April 2002. doi:10.1073/pnas.082117899. PMID 11959990. Bibcode: 2002PNAS...99.5367F.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=122775
13. "Anaerobic Glycolysis and HIF1α Expression in Haematopoietic Stem Cells Explains Its Quiescence Nature". Journal of Stem Cells 10 (2): 97–106. 2015. PMID 27125138.  http://www.ncbi.nlm.nih.gov/pubmed/27125138
14. "The magic of the hypoxia-signaling cascade". Cellular and Molecular Life Sciences 65 (7–8): 1133–49. April 2008. doi:10.1007/s00018-008-7472-0. PMID 18202826.  https://dx.doi.org/10.1007%2Fs00018-008-7472-0
15. "Regulation of human metabolism by hypoxia-inducible factor". Proceedings of the National Academy of Sciences of the United States of America 107 (28): 12722–7. July 2010. doi:10.1073/pnas.1002339107. PMID 20616028. Bibcode: 2010PNAS..10712722F.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2906567
16. "The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis". Nature 399 (6733): 271–5. May 1999. doi:10.1038/20459. PMID 10353251. Bibcode: 1999Natur.399..271M.  https://dx.doi.org/10.1038%2F20459
17. Perkel, Jeffrey (May 2001). "Seeking a Cellular Oxygen Sensor". The Scientist. https://www.the-scientist.com/research/seeking-a-cellular-oxygen-sensor-54701. Retrieved 7 October 2019. 
18. "Hydroxylation of HIF-1: oxygen sensing at the molecular level". Physiology 19 (4): 176–82. August 2004. doi:10.1152/physiol.00001.2004. PMID 15304631. https://semanticscholar.org/paper/c7526355ac1f22e25e25a6cd8a3ca7673ef20ef3. 
19. Russo, Eugene (April 2003). "Discovering HIF Regulation". The Scientist. https://www.the-scientist.com/hot-paper/discovering-hif-regulation-51758. Retrieved 7 October 2019. 
20. "Hypoxia induces rapid changes to histone methylation and reprograms chromatin.". Science 363 (6432): 1222–1226. 2019. doi:10.1126/science.aau5870. PMID 30872526. Bibcode: 2019Sci...363.1222B.  https://dx.doi.org/10.1126%2Fscience.aau5870
21. "Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate.". Science 363 (6432): 1217–1222. 2019. doi:10.1126/science.aaw1026. PMID 30872525. Bibcode: 2019Sci...363.1217C. http://urn.fi/urn:nbn:fi-fe201903259863. 
22. "Histone modifiers are oxygen sensors.". Science 363 (6432): 1148–1149. 2019. doi:10.1126/science.aaw8373. PMID 30872506. Bibcode: 2019Sci...363.1148G.  https://dx.doi.org/10.1126%2Fscience.aaw8373
23. "mAKAP compartmentalizes oxygen-dependent control of HIF-1alpha". Science Signaling 1 (51): ra18. December 2008. doi:10.1126/scisignal.2000026. PMID 19109240.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2828263
24. "Regulation of hypoxia-inducible factor-1alpha by NF-kappaB". The Biochemical Journal 412 (3): 477–84. June 2008. doi:10.1042/BJ20080476. PMID 18393939.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2474706
25. "Hypoxic regulation of erythropoiesis and iron metabolism". American Journal of Physiology. Renal Physiology 299 (1): F1–13. July 2010. doi:10.1152/ajprenal.00174.2010. PMID 20444740.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2904169
26. eurekalert.org staff (3 June 2015). "Scientist at LIMR leads study demonstrating drug-induced tissue regeneration". Lankenau Institute for Medical Research (LIMR). http://www.eurekalert.org/pub_releases/2015-06/mlhl-sal060215.php. Retrieved 3 July 2015. 
27. "Drug-induced regeneration in adult mice". Science Translational Medicine 7 (290): 290ra92. June 2015. doi:10.1126/scitranslmed.3010228. PMID 26041709.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4687906
28. "Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases". Current Medicinal Chemistry 14 (17): 1853–62. 2007. doi:10.2174/092986707781058850. PMID 17627521.  https://dx.doi.org/10.2174%2F092986707781058850
29. "HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond". Nature Reviews. Nephrology 12 (3): 157–68. March 2016. doi:10.1038/nrneph.2015.193. PMID 26656456. https://www.repository.cam.ac.uk/handle/1810/253687. 
30. "A New Approach to the Management of Anemia in CKD Patients: A Review on Roxadustat". Advances in Therapy 34 (4): 848–853. 2017. doi:10.1007/s12325-017-0508-9. PMID 28290095.  https://dx.doi.org/10.1007%2Fs12325-017-0508-9
31. "Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease". Kidney International 90 (5): 1115–1122. 2016. doi:10.1016/j.kint.2016.07.019. PMID 27650732.  https://dx.doi.org/10.1016%2Fj.kint.2016.07.019
32. "Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia". The Journal of Pharmacology and Experimental Therapeutics 363 (3): 336–347. 2017. doi:10.1124/jpet.117.242503. PMID 28928122.  https://dx.doi.org/10.1124%2Fjpet.117.242503
33. "Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers". Clinical Pharmacokinetics 57 (1): 87–102. May 2017. doi:10.1007/s40262-017-0551-3. PMID 28508936.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5766731
34. "Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85-3934 (Molidustat) stimulates erythropoietin production without hypertensive effects". PLOS ONE 9 (11): e111838. 2014. doi:10.1371/journal.pone.0111838. PMID 25392999. Bibcode: 2014PLoSO...9k1838F.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4230943
35. "The latest advances in kidney diseases and related disorders". Drug News & Perspectives 20 (10): 647–54. December 2007. PMID 18301799. http://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summaryn_pr?p_JournalId=3&p_RefId=3919. 
36. "Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia". Journal of Medicinal Chemistry 59 (24): 11039–11049. December 2016. doi:10.1021/acs.jmedchem.6b01242. PMID 28002958.  https://dx.doi.org/10.1021%2Facs.jmedchem.6b01242
37. "YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1". Journal of the National Cancer Institute 95 (7): 516–25. April 2003. doi:10.1093/jnci/95.7.516. PMID 12671019.  https://dx.doi.org/10.1093%2Fjnci%2F95.7.516
38. "Impairment of hypoxia-induced HIF-1α signaling in keratinocytes and fibroblasts by sulfur mustard is counteracted by a selective PHD-2 inhibitor". Archives of Toxicology 90 (5): 1141–50. May 2016. doi:10.1007/s00204-015-1549-y. PMID 26082309.  https://dx.doi.org/10.1007%2Fs00204-015-1549-y
39. "Cancer therapeutic agents targeting hypoxia-inducible factor-1". Current Medicinal Chemistry 18 (21): 3168–89. 2011. doi:10.2174/092986711796391606. PMID 21671859.  https://dx.doi.org/10.2174%2F092986711796391606
40. "Discovery of Indenopyrazoles as a New Class of Hypoxia Inducible Factor (HIF)-1 Inhibitors". ACS Medicinal Chemistry Letters 4 (2): 297–301. February 2013. doi:10.1021/ml3004632. PMID 24900662.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4027554
41. "A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection". Journal of Molecular Medicine 90 (9): 1079–89. September 2012. doi:10.1007/s00109-012-0882-3. PMID 22371073.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3606899
42. "Hypoxia-Dependent HIF-1 Activation Impacts on Tissue Remodeling in Graves' Ophthalmopathy-Implications for Smoking". The Journal of Clinical Endocrinology and Metabolism 101 (12): 4834–4842. December 2016. doi:10.1210/jc.2016-1279. PMID 27610652.  https://dx.doi.org/10.1210%2Fjc.2016-1279
43. "Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis". Drug Test Anal 4 (11): 830–45. 2012. doi:10.1002/dta.390. PMID 22362605.  https://dx.doi.org/10.1002%2Fdta.390
44. "FG-4497: a new target for acute respiratory distress syndrome?". Expert Review of Respiratory Medicine 9 (4): 405–9. August 2015. doi:10.1586/17476348.2015.1065181. PMID 26181437.  https://dx.doi.org/10.1586%2F17476348.2015.1065181
45. "HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques". Blood 110 (6): 2140–7. September 2007. doi:10.1182/blood-2007-02-073254. PMID 17557894.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1976368
46. "The FDA Accepts the Complete Response for Clinical Holds of FG-2216/FG-4592 for the Treatment of Anemia". http://www.astellas.com/en/corporate/news/pdf/080402_eg.pdf. 
47. "Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases". Nature Reviews. Drug Discovery 13 (11): 852–69. November 2014. doi:10.1038/nrd4422. PMID 25359381.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4259899
48. "AMPK and HIF signaling pathways regulate both longevity and cancer growth: the good news and the bad news about survival mechanisms". Biogerontology 17 (4): 655–80. August 2016. doi:10.1007/s10522-016-9655-7. PMID 27259535.  https://dx.doi.org/10.1007%2Fs10522-016-9655-7
49. "Hypoxia-dependent regulation of inflammatory pathways in immune cells". The Journal of Clinical Investigation 126 (10): 3716–3724. October 2016. doi:10.1172/JCI84433. PMID 27454299.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5096820
50. "The role of HIF in immunity and inflammation". Molecular Aspects of Medicine 47–48: 24–34. 2016. doi:10.1016/j.mam.2015.12.004. PMID 26768963.  https://dx.doi.org/10.1016%2Fj.mam.2015.12.004
51. "Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis". Frontiers in Pharmacology 7: 184. 2016. doi:10.3389/fphar.2016.00184. PMID 27445820.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4921475
52. "Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer". Cell & Bioscience 7: 62. 2017. doi:10.1186/s13578-017-0190-2. PMID 29158891.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5683220
53. "Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?". Science China Life Sciences 60 (10): 1114–1124. October 2017. doi:10.1007/s11427-017-9178-y. PMID 29039125.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=6131113
54. "NF-κB and HIF crosstalk in immune responses". The FEBS Journal 283 (3): 413–24. February 2016. doi:10.1111/febs.13578. PMID 26513405.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4864946
55. "Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization". Proceedings of the National Academy of Sciences of the United States of America 106 (42): 17910–5. October 2009. doi:10.1073/pnas.0909353106. PMID 19805192. Bibcode: 2009PNAS..10617910L.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2764905
56. "In vivo modulation of 4E binding protein 1 (4E-BP1) phosphorylation by watercress: a pilot study". The British Journal of Nutrition 104 (9): 1288–96. November 2010. doi:10.1017/S0007114510002217. PMID 20546646.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3694331
57. "Evaluation of HIF-1 inhibitors as anticancer agents". Drug Discovery Today 12 (19–20): 853–9. October 2007. doi:10.1016/j.drudis.2007.08.006. PMID 17933687.  https://dx.doi.org/10.1016%2Fj.drudis.2007.08.006
58. "Inhibiting hypoxia-inducible factor 1 for cancer therapy". Molecular Cancer Research 4 (9): 601–5. September 2006. doi:10.1158/1541-7786.MCR-06-0235. PMID 16940159.  https://dx.doi.org/10.1158%2F1541-7786.MCR-06-0235
59. "Hypoxia inducible factor stabilization leads to lasting improvement of hippocampal memory in healthy mice". Behavioural Brain Research 208 (1): 80–4. March 2010. doi:10.1016/j.bbr.2009.11.010. PMID 19900484.  https://dx.doi.org/10.1016%2Fj.bbr.2009.11.010
60. "HIF-1α Activation Attenuates IL-6 and TNF-α Pathways in Hippocampus of Rats Following Transient Global Ischemia". Cellular Physiology and Biochemistry 39 (2): 511–20. 2016. doi:10.1159/000445643. PMID 27383646.  https://dx.doi.org/10.1159%2F000445643
61. "Effect of hypoxia-inducible factor-1/vascular endothelial growth factor signaling pathway on spinal cord injury in rats". Experimental and Therapeutic Medicine 13 (3): 861–866. March 2017. doi:10.3892/etm.2017.4049. PMID 28450910.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5403438